BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31769744)

  • 1. Nonhomogeneous Gadolinium Retention in the Cerebral Cortex after Intravenous Administration of Gadolinium-based Contrast Agent in Rats and Humans.
    Minaeva O; Hua N; Franz ES; Lupoli N; Mian AZ; Farris CW; Hildebrandt AM; Kiernan PT; Evers LE; Griffin AD; Liu X; Chancellor SE; Babcock KJ; Moncaster JA; Jara H; Alvarez VE; Huber BR; Guermazi A; Latour LL; McKee AC; Soto JA; Anderson SW; Goldstein LE
    Radiology; 2020 Feb; 294(2):377-385. PubMed ID: 31769744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium Deposition in the Rat Brain Measured with Quantitative MRI versus Elemental Mass Spectrometry.
    Hua N; Minaeva O; Lupoli N; Franz ES; Liu X; Moncaster JA; Babcock KJ; Jara H; Tripodis Y; Guermazi A; Soto JA; Anderson SW; Goldstein LE
    Radiology; 2023 Jan; 306(1):244-251. PubMed ID: 36125373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
    Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
    Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration.
    Ayers-Ringler J; McDonald JS; Connors MA; Fisher CR; Han S; Jakaitis DR; Scherer B; Tutor G; Wininger KM; Dai D; Choi DS; Salisbury JL; Jannetto PJ; Bornhorst JA; Kadirvel R; Kallmes DF; McDonald RJ
    Radiology; 2022 Mar; 302(3):676-683. PubMed ID: 34931861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium Retention in the Central and Peripheral Nervous System: Implications for Pain, Cognition, and Neurogenesis.
    Alkhunizi SM; Fakhoury M; Abou-Kheir W; Lawand N
    Radiology; 2020 Nov; 297(2):407-416. PubMed ID: 32808889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Retention of Gadolinium in the Inflamed Brain After Repeated Administration of Gadopentetate Dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF.
    Wang S; Hesse B; Roman M; Stier D; Castillo-Michel H; Cotte M; Suuronen JP; Lagrange A; Radbruch H; Paul F; Taupitz M; Schellenberger E; Sack I; Infante-Duarte C
    Invest Radiol; 2019 Oct; 54(10):617-626. PubMed ID: 31033673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions.
    Boyken J; Frenzel T; Lohrke J; Jost G; Pietsch H
    Invest Radiol; 2018 May; 53(5):278-285. PubMed ID: 29319556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose Administrations of Gadodiamide and Gadobutrol.
    Hummel L; Frenzel T; Boyken J; Pietsch H; Seeliger E
    Invest Radiol; 2024 Feb; 59(2):150-164. PubMed ID: 38157437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model.
    Jost G; Frenzel T; Boyken J; Lohrke J; Nischwitz V; Pietsch H
    Radiology; 2019 Feb; 290(2):340-348. PubMed ID: 30422091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Gadolinium Retention in the Healthy Rat Brain: Comparison between Gadopiclenol, Gadobutrol, and Gadodiamide.
    Funke SKI; Factor C; Rasschaert M; Lezius L; Sperling M; Karst U; Robert P
    Radiology; 2022 Oct; 305(1):179-189. PubMed ID: 35727155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
    McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
    Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate.
    Kobayashi M; Levendovszky SR; Hippe DS; Hasegawa M; Murata N; Murata K; Marshall DA; Gonzalez-Cuyar LF; Maravilla KR
    Radiology; 2021 Sep; 300(3):559-569. PubMed ID: 34128720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium Retention in the Rat Brain: Assessment of the Amounts of Insoluble Gadolinium-containing Species and Intact Gadolinium Complexes after Repeated Administration of Gadolinium-based Contrast Agents.
    Gianolio E; Bardini P; Arena F; Stefania R; Di Gregorio E; Iani R; Aime S
    Radiology; 2017 Dec; 285(3):839-849. PubMed ID: 28873047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain.
    Anderhalten L; Silva RV; Morr A; Wang S; Smorodchenko A; Saatz J; Traub H; Mueller S; Boehm-Sturm P; Rodriguez-Sillke Y; Kunkel D; Hahndorf J; Paul F; Taupitz M; Sack I; Infante-Duarte C
    Invest Radiol; 2022 Oct; 57(10):677-688. PubMed ID: 35467573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
    Young JR; Qiao J; Orosz I; Salamon N; Franke MA; Kim HJ; Pope WB
    Eur Radiol; 2018 Nov; 28(11):4882-4889. PubMed ID: 29744642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
    Cao Y; Huang DQ; Shih G; Prince MR
    AJR Am J Roentgenol; 2016 Feb; 206(2):414-9. PubMed ID: 26700156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.